Dr. Satish Sharma, MD, FACS, Urologic Surgeon, is a Research Associate Professor of Urology, Department of Urology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, NY. He is the Clinical Director of the Prostate Cancer Research Program at the Department of Medicine, University at Buffalo. He is a Fellow of the American College of Surgeons, a member of the American Urologic Association and American College of Surgeons. He is the recipient of the Union of International Cancer Control Award and the Norwegian Cancer Society fellowship award. He has remained on the adjunct faculty of Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania, as a clinical instructor. Dr. Sharma completed his medical degree in 1986. He has multiple research and clinical fellowship training to his credit. He completed research and clinical fellowship in urologic oncology at Roswell Park Cancer Institute, Buffalo, NY. He completed a research fellowship in renal transplantation at the Department of Surgery, Buffalo General Hospital. His expertise is in the diagnosis and management of general and oncological genitourinary problems with a focus on minimally invasive procedures, including minimally invasive treatment of urinary tract calculi. He has publications to his credit. He has been instrumental in building a large prostate cancer and Kidney cancer database that led to clinical research and numerous publications.
Dr. Supriya D. Mahajan has established herself as an investigator in the area of neuropathogenesis of HIV-1 in the context of drug abuse. She has established 2D and 3D Blood Brain Barrier (BBB) models, that allow studying mechanisms of BBB pathophysiology, examine BBB integrity and evaluate permeability of neurotherapeutics across the BBB. She has expanded her research work to include Nanotechnology based therapeutics for cancer and neurological diseases. Her focus has always been on collaborative, interdisciplinary partnerships between various Departments within UB including the Institute of Lasers, Photonics and Biophotonics, Research Institute of Addiction, Dept of Computer Science and Engineering, Dept of Pharmaceutical Sciences, Dept of Oral Biology and the Department of Bioengineering and also multi-institutional collaborations with University of Rochester Medical Center and SUNY Albany. Dr. Mahajan is Director of Research of the Division of Allergy, Immunology & Rheumatology. She supervises the research training of the Allergy fellows, Medical residents, graduate and undergraduate students. Dr. Mahajan has presented her research work at National and International conferences and was an invited speaker at several seminars and colloquiums. She has authored over 150 publications in several top-quality peer-reviewed journals.
Dr. Paras N. Prasad was born in 1946 in Bihar (India). In 1966, he obtained an MSc. from Bihar University (India) and in 1971 a Ph.D. at the University of Pennsylvania (U.S.A.). As a postdoctoral Fellow, he worked at the University of Michigan from 1971 to 1974. He is a Distinguished Professor of Chemistry, Physics, Medicine, and Electrical Engineering, the highest rank in the New York State University system. He also holds the Samuel P. Capen Chair at the University at Buffalo, and since 1999, he has been the Executive Director of the multidisciplinary Institute for Lasers, Photonics and Biophotonics. His Multidisciplinary research is in the field of photonics and nonlinear optics. He has received much recognition (honorary doctorates, fellowships, medals) for his pioneering contributions. He received Scientific American’s Top 50 (2005); he is a Fellow of the American Physical Society, a Fellow of the Optical Society of America, and National Academy of Inventors (2016). For his pioneering work on “Nanoclinics” for Biophotonics, he was also awarded the Technology/Discovery award from the Western New York Health Care Industries Association. He received an honorary doctorate from the Royal Institute of Technology in Sweden (KTH) for his pioneering work in areas including the use of light-based technologies to address important, global health problems.
Dr. Stanley A. Schwartz is a Professor of Pediatrics, Medicine, University at Buffalo. He obtained an MSc in Microbiology at Rutgers University in 1965, and in 1968 he received his PhD in Cellular Biology at University of California, San Diego. He earned a Postdoctoral Scholarship, Albert Einstein College of Medicine in 1969, Clinical Research Fellowship in 1972, Sustained Academic Achievement Award in 2002, Stockton Kimball Award in 2003, and UB Distinguished Professor in 2011. He was also listed in Best Doctors in the U.S. and Guide to America’s Top Physicians, Consumers’ Research Council. His research interests include Allergy and Immunology: Asthma, allergic rhinitis, urticaria, atopic dermatitis, cutaneous vasculitis, primary immunodeficiency, and hereditary angioedema. And Immunology: Pathogenesis of HIV Encephalopathy Role of Angiogenesis in Cancer, Mechanisms of Airway Remodeling in Asthma.
